Abiraterone Tablet
Product Images NDC 68001-673

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Abiraterone (NDC 68001-673). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Abiraterone 250mg 120s Container Label)

Label for Abiraterone Acetate Tablets USP, 250 mg strength, oral tablet form, supplied in a package of 120 tablets. The label includes storage instructions, a warning for pregnant women, manufacturer details (MSN Laboratories Private Limited, India), and the labeler BluePoint Laboratories. NDC 68001-489-07 is shown alongside barcode and revision date.*

FDA Label Image

Figure-01 (Abiraterone Figure 01)

A survival curve chart showing percentage survival over time to death in months. Two lines represent groups labeled Abiraterone and Placebo, with Abiraterone showing higher survival percentage throughout the time span up to 21 months. The chart includes participant counts at various time points for each group below the x-axis.*

FDA Label Image

Figure-02 (Abiraterone Figure 02)

A Kaplan-Meier survival curve chart comparing Abiraterone and placebo over months from randomization. The y-axis shows the percentage of subjects without death, with survival declining over time for both groups. The chart includes a patient number table below the x-axis for each treatment group at various time points.*

FDA Label Image

Figure-03 (Abiraterone Figure 03)

A Kaplan-Meier survival curve chart showing the percentage of subjects without radiographic progression or death over time (months from randomization). The chart compares two groups: Abiraterone (solid line) and Placebo (dashed line), with the number of subjects at risk listed below the x-axis for each time point. The y-axis represents the percentage of subjects without progression or death from 0 to 100%, and the x-axis represents months up to 18.*

FDA Label Image

Abiraterone-structure (Abiraterone Structure)

Chemical structure diagram of Abiraterone Acetate showing the arrangement of atoms and bonds in the molecule.*

FDA Label Image

Figure 4

A Kaplan-Meier survival curve graph showing the percentage of subjects without death over months from randomization comparing Abiraterone and Placebo groups. The x-axis represents months from randomization, and the y-axis shows the percentage survival rate. The graph includes a table of subjects at risk over time for both Abiraterone and Placebo groups, with distinct markers for each group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.